BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28934971)

  • 1. Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA).
    Orandi AB; Baszis KW; Dharnidharka VR; Huber AM; Hoeltzel MF;
    Pediatr Rheumatol Online J; 2017 Sep; 15(1):71. PubMed ID: 28934971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH; Speth F; Oommen PT; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance.
    Sherman MA; Kim H; Banschbach K; Brown A; Gewanter HL; Lang B; Perron M; Robinson AB; Spitznagle J; Stingl C; Syverson G; Tory HO; Spencer CH; Tarvin SE
    Pediatr Rheumatol Online J; 2023 Jan; 21(1):3. PubMed ID: 36609397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists.
    Nicek A; Talib N; Lovell D; Smith C; Becker ML; Jones JT
    Pediatr Rheumatol Online J; 2020 Jul; 18(1):57. PubMed ID: 32660497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
    Stringer E; Bohnsack J; Bowyer SL; Griffin TA; Huber AM; Lang B; Lindsley CB; Ota S; Pilkington C; Reed AM; Scuccimarri R; Feldman BM
    J Rheumatol; 2010 Sep; 37(9):1953-61. PubMed ID: 20595275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
    Shenoi S; Nanda K; Schulert GS; Bohnsack JF; Cooper AM; Edghill B; Gillispie-Taylor MC; Goldberg B; Halyabar O; Mason TG; Ronis T; Schneider R; Vehe RK; Onel K;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):48. PubMed ID: 31331351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.
    Neely J; Ardalan K; Huber A; Kim S;
    Pediatr Rheumatol Online J; 2022 Jul; 20(1):50. PubMed ID: 35854378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
    Tayfur AC; Topaloglu R; Gulhan B; Bilginer Y
    Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.
    Kim S; Kahn P; Robinson AB; Lang B; Shulman A; Oberle EJ; Schikler K; Curran ML; Barillas-Arias L; Spencer CH; Rider LG; Huber AM
    Pediatr Rheumatol Online J; 2017 Jan; 15(1):1. PubMed ID: 28077146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
    Westwell-Roper C; Lubieniecka JM; Brown KL; Morishita KA; Mammen C; Wagner-Weiner L; Yen E; Li SC; O'Neil KM; Lapidus SK; Brogan P; Cimaz R; Cabral DA;
    Pediatr Rheumatol Online J; 2017 Aug; 15(1):61. PubMed ID: 28784150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Neely J; Long CS; Sturrock H; Kim S;
    Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1600-1605. PubMed ID: 30714338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.
    Hinze CH; Oommen PT; Dressler F; Urban A; Weller-Heinemann F; Speth F; Lainka E; Brunner J; Fesq H; Foell D; Müller-Felber W; Neudorf U; Rietschel C; Schwarz T; Schara U; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):40. PubMed ID: 29940960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
    Hoeltzel MF; Oberle EJ; Robinson AB; Agarwal A; Rider LG
    Curr Rheumatol Rep; 2014 Dec; 16(12):467. PubMed ID: 25366934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance.
    Wenderfer SE; Lane JC; Shatat IF; von Scheven E; Ruth NM
    Pediatr Rheumatol Online J; 2015 Jun; 13():26. PubMed ID: 26087651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
    Phillippi K; Hoeltzel M; Byun Robinson A; Kim S;
    J Pediatr; 2017 May; 184():38-44.e1. PubMed ID: 28410093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry.
    Tory H; Zurakowski D; Kim S;
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):5. PubMed ID: 31941511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
    Huber AM; Kim S; Reed AM; Carrasco R; Feldman BM; Hong SD; Kahn P; Rahimi H; Robinson AB; Vehe RK; Weiss JE; Spencer C;
    J Rheumatol; 2017 Jan; 44(1):110-116. PubMed ID: 27803135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice-based differences in paediatric discoid lupus erythematosus.
    Arkin LM; Buhr K; Brandling-Bennett H; Chiu Y; Chong B; Curran M; Hunt R; Paller AS; Werth VP; Klein-Gitelman M; von Scheven E; Ardalan K
    Br J Dermatol; 2019 Oct; 181(4):805-810. PubMed ID: 30768778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
    Knight AM; Vickery ME; Muscal E; Davis AM; Harris JG; Soybilgic A; Onel KB; Schanberg LE; Rubinstein T; Gottlieb BS; Mandell DS; von Scheven E;
    J Rheumatol; 2016 Jun; 43(6):1136-45. PubMed ID: 27036378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.